Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 6/20 | 0.78 |
| ▸ | TP53 | P04637 | 3/20 | 0.78 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.78 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.78 |
| ▸ | TSHR | P16473 | 1/20 | 0.78 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.65 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.65 |
| ▸ | LMNA | P02545 | 4/20 | 0.57 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.56 |
| ▸ | RAB9A | P51151 | 6/20 | 0.56 |
| ▸ | NPC1 | O15118 | 5/20 | 0.56 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.56 |
| ▸ | MAPT | P10636 | 2/20 | 0.56 |
| ▸ | PKM | P14618 | 2/20 | 0.56 |
| ▸ | SCN4A | P35499 | 2/20 | 0.56 |
| ▸ | HTT | P42858 | 1/20 | 0.56 |
| ▸ | GMNN | O75496 | 1/20 | 0.56 |
| ▸ | USP2 | O75604 | 1/20 | 0.56 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.56 |
| ▸ | GAA | P10253 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL11613963 | 0.98 | CYP3A4 (0.76) | CYP3A4TP53HSD17B10ALDH1A1TSHR | |
| SCHEMBL5946843 | 0.94 | CYP3A4 (0.78) | CYP3A4TP53HSD17B10ALDH1A1TSHR | |
| SCHEMBL5047405 | 0.90 | CYP3A4 (0.72) | CYP3A4TP53HSD17B10ALDH1A1TSHR | |
| SCHEMBL11344342 | 0.90 | CYP3A4 (0.72) | CYP3A4TP53HSD17B10ALDH1A1TSHR | |
| SCHEMBL16240828 | 0.90 | CYP3A4 (0.72) | CYP3A4TP53HSD17B10ALDH1A1TSHR | |
| SCHEMBL6811786 | 0.90 | CYP3A4 (0.72) | CYP3A4TP53HSD17B10ALDH1A1TSHR | |
| SCHEMBL233589 | 0.88 | CYP3A4 (1.00) | CYP3A4TP53HSD17B10ALDH1A1TSHR | |
| SCHEMBL17963034 | 0.87 | CYP3A4 (0.71) | CYP3A4TP53HSD17B10ALDH1A1TSHR | |
| SCHEMBL9722836 | 0.85 | CYP3A4 (0.68) | CYP3A4TP53HSD17B10ALDH1A1TSHR | |
| SCHEMBL1848550 | 0.85 | CYP3A4 (0.68) | CYP3A4TP53HSD17B10ALDH1A1TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-1197916-C | Olive green cationic dye and its preparing method | SHANGHAI CITY DYESTUFF INST (CN) | 2005-04-20 | — | — | CN | claimed |
| CN-1445287-A | Olive green cationic dye and its preparing method | SHANGHAI CITY DYESTUFF INST (CN) | 2003-10-01 | — | — | CN | claimed |
| EP-3827665-B1 | MAMMAL KINASE INHIBITORS TO PROMOTE IN VITRO EMBRYOGENESIS INDUCTION OF PLANTS | CONSEJO SUPERIOR INVESTIGACION (ES) | 2025-02-19 | — | — | EP | disclosed |
| US-11912678-B2 | LRRK2 inhibiting compounds and use thereof for treating neurodegenerative diseases | CONSEJO SUPERIOR DE INVESTIGACIONES CIENTÍFICAS (ES) | 2024-02-27 | — | — | US | disclosed |
| US-20230025843-A1 | MAMMAL KINASE INHIBITORS TO PROMOTE IN VITRO EMBRYOGENESIS INDUCTION OF PLANTS | CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC) (ES) | 2023-01-26 | — | — | US | disclosed |
| EP-3842422-B1 | LRRK2 INHIBITING COMPOUNDS AND USE THEREOF FOR TREATING NEURODEGENERATIVE DISEASES | CONSEJO SUPERIOR INVESTIGACION (ES) | 2022-09-07 | — | — | EP | disclosed |
| US-20210323936-A1 | LRRK2 INHIBITING COMPOUNDS AND USE THEREOF FOR TREATING NEURODEGENERATIVE DISEASES | CONSEJO SUPERIOR DE INVESTIGACIONES CIENTÍFICAS (ES) | 2021-10-21 | — | — | US | disclosed |
| EP-3842422-A1 | LRRK2 INHIBITING COMPOUNDS AND USE THEREOF FOR TREATING NEURODEGENERATIVE DISEASES | Consejo Superior de Investigaciones Cientificas (ES) | 2021-06-30 | — | — | EP | disclosed |
| WO-2021105182-A1 | MAMMAL KINASE INHIBITORS TO PROMOTE IN VITRO EMBRYOGENESIS INDUCTION OF PLANTS | CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC) (ES) | 2021-06-03 | — | — | WO | disclosed |
| EP-3827665-A1 | MAMMAL KINASE INHIBITORS TO PROMOTE IN VITRO EMBRYOGENESIS INDUCTION OF PLANTS | Consejo Superior de Investigaciones Científicas (CSIC) (ES) | 2021-06-02 | — | — | EP | disclosed |
| WO-2020039110-A1 | LRRK2 INHIBITING COMPOUNDS AND USE THEREOF FOR TREATING NEURODEGENERATIVE DISEASES | CONSEJO SUPERIOR DE INVESTIGACIONES CIENTÍFICAS (ES) | 2020-02-27 | — | — | WO | disclosed |
| EP-0349486-A2 | Azo dyes, their preparation and their use | CIBA-GEIGY AG (CH) | 1990-01-03 | — | — | EP | disclosed |
| EP-0105031-B1 | CATIONIC AZO DYESTUFFS | CIBA-GEIGY AG (CH) | 1989-01-04 | — | — | EP | disclosed |
| EP-0105031-A2 | Cationic azo dyestuffs | CIBA-GEIGY AG (CH) | 1984-04-04 | — | — | EP | disclosed |
| US-4252716-A | BLUE SHADES | BAYER AKTIENGESELLSCHAFT (DE) | 1981-02-24 | — | — | US | disclosed |
| US-4051084-A | BENZOTHIAZOLE | BAYER AKTIENGESELLSCHAFT (DT) | 1977-09-27 | — | — | US | disclosed |
| US-4039526-A | PRINTING, POLYACRYLONITRILE, POLYESTERS, POLYAMIDES | BAYER AKTIENGESELLSCHAFT (DT) | 1977-08-02 | — | — | US | disclosed |
| US-4006242-A | Certain benzothiazoles used in the treatment of helminthiasis | SCHERING CORPORATION (US) | 1977-02-01 | — | — | US | disclosed |
| US-3991042-A | Basic azo dyestuffs containing a benzthiazole and a tetrahydroquinoline nucleus | BAYER AKTIENGESELLSCHAFT (DT) | 1976-11-09 | — | — | US | disclosed |
| US-3948877-A | POLYACRYLONITRILE, ACID MODIFIED POLYESTERS OR POLYAMIDES | BAYER AKTIENGESELLSCHAFT (DT) | 1976-04-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210323936-A1 | LRRK2 INHIBITING COMPOUNDS AND USE THEREOF FOR TREATING NEURODEGENERATIVE DISEASES | LRRK2, PARK7, SNCA | CYP3A4 3809/4885TP53 3008/4885HSD17B10 1864/4885 |
| US-11912678-B2 | LRRK2 inhibiting compounds and use thereof for treating neurodegenerative diseases | LRRK2, PARK7, SNCA | CYP3A4 3809/4885TP53 3008/4885HSD17B10 1864/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.